Skip to main content
Premium Trial:

Request an Annual Quote

More Bumps in the PGx Road

For years, Herceptin has been hailed as a major success in the tailored-medicine landscape. The breast cancer drug is prescribed to women who test positive for a gene or for certain levels of protein on the tumor. But new studies indicate that women who test negative for these things still benefit from taking Herceptin -- and experts say "as many as 40 percent of women with early breast cancer might benefit from the drug but are not getting it," according to this New York Times article.


The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.